Transfer of MicroRNA via Macrophage-Derived Extracellular Vesicles Promotes Proneural-to-Mesenchymal Transition in Glioma Stem Cells
- PMID: 32350000
- DOI: 10.1158/2326-6066.CIR-19-0759
Transfer of MicroRNA via Macrophage-Derived Extracellular Vesicles Promotes Proneural-to-Mesenchymal Transition in Glioma Stem Cells
Abstract
Proneural-to-mesenchymal transition (PMT) is a common process in glioblastoma (GBM) progression that leads to increased radiotherapy resistance. However, the mechanism underlying PMT is poorly understood. Here, we found that tumor-associated macrophages triggered PMT in glioma stem cells (GSC) via small extracellular vesicles (sEV). sEVs from monocyte-derived macrophages transferred miR-27a-3p, miR-22-3p, and miR-221-3p to GSCs, and these miRNAs promoted several mesenchymal phenotypes in proneural (PN) GSCs by simultaneously targeting CHD7 We found that CHD7 played a critical role in the maintenance of the PN phenotype, and CHD7 knockdown significantly promoted PMT in GSCs via the RelB/P50 and p-STAT3 pathways. The induction of PMT by sEVs containing miR-27a-3p, miR-22-3p, and miR-221-3p in a xenograft nude mouse model exacerbated radiotherapy resistance and thus decreased the benefits of radiotherapy. Collectively, these findings identified macrophage-derived sEVs as key regulators of PMT in GSCs and demonstrated that CHD7 is a novel inhibitor of PMT.
©2020 American Association for Cancer Research.
Similar articles
-
Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.Theranostics. 2021 Jan 1;11(4):1763-1779. doi: 10.7150/thno.47057. eCollection 2021. Theranostics. 2021. PMID: 33408780 Free PMC article.
-
Neuronal Activity Promotes Glioma Progression by Inducing Proneural-to-Mesenchymal Transition in Glioma Stem Cells.Cancer Res. 2024 Feb 1;84(3):372-387. doi: 10.1158/0008-5472.CAN-23-0609. Cancer Res. 2024. PMID: 37963207
-
MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.FASEB J. 2020 Apr;34(4):5128-5143. doi: 10.1096/fj.201802629RR. Epub 2020 Feb 17. FASEB J. 2020. PMID: 32067282
-
Stem cell signature in glioblastoma: therapeutic development for a moving target.J Neurosurg. 2015 Feb;122(2):324-30. doi: 10.3171/2014.9.JNS132253. Epub 2014 Nov 14. J Neurosurg. 2015. PMID: 25397368 Review.
-
New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.J Cell Physiol. 2014 Sep;229(9):1141-7. doi: 10.1002/jcp.24540. J Cell Physiol. 2014. PMID: 24374932 Review.
Cited by
-
Subtype Transdifferentiation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression.Cells. 2024 Feb 17;13(4):350. doi: 10.3390/cells13040350. Cells. 2024. PMID: 38391963 Free PMC article. Review.
-
miRNA-194-3p represses NF-κB in gliomas to attenuate iPSC genes and proneural to mesenchymal transition.iScience. 2023 Dec 7;27(1):108650. doi: 10.1016/j.isci.2023.108650. eCollection 2024 Jan 19. iScience. 2023. PMID: 38226170 Free PMC article.
-
Shooting the messenger: a systematic review investigating extracellular vesicle isolation and characterisation methods and their influence on understanding extracellular vesicles-radiotherapy interactions in glioblastoma.BMC Cancer. 2023 Oct 5;23(1):939. doi: 10.1186/s12885-023-11437-6. BMC Cancer. 2023. PMID: 37798728 Free PMC article.
-
Cancer stem cells in brain tumors: From origin to clinical implications.MedComm (2020). 2023 Aug 9;4(4):e341. doi: 10.1002/mco2.341. eCollection 2023 Aug. MedComm (2020). 2023. PMID: 37576862 Free PMC article. Review.
-
New Possible Ways to Use Exosomes in Diagnostics and Therapy via JAK/STAT Pathways.Pharmaceutics. 2023 Jul 7;15(7):1904. doi: 10.3390/pharmaceutics15071904. Pharmaceutics. 2023. PMID: 37514090 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
